The Hydration Pharmaceuticals Company Ltd Cash Flow Conversion Efficiency
The Hydration Pharmaceuticals Company Ltd cash flow conversion efficiency. Based on the latest financial reports, The Hydration Pharmaceuticals Company Ltd (HPC) has a cash flow conversion efficiency ratio of -0.606x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.64 Million ≈ $-1.16 Million USD) by net assets (AU$2.71 Million ≈ $1.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of The Hydration Pharmaceuticals Company Ltd (2018–2024)
Cash flow conversion efficiency of The Hydration Pharmaceuticals Company Ltd from 2018 to 2024. This chart illustrates how The Hydration Pharmaceuticals Company Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View The Hydration Pharmaceuticals Company Lt (HPC) stock price for real-time trading data and today's change.
The Hydration Pharmaceuticals Company Ltd Cash Flow Conversion Ratio Explained
The Hydration Pharmaceuticals Company Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
The Hydration Pharmaceuticals Company Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of The Hydration Pharmaceuticals Company Ltd ranked by their cash flow conversion efficiency. Also see how much is The Hydration Pharmaceuticals Company Lt worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Panther Securities P L C
LSE:PNS
|
0.008x |
|
IO Biotech Inc
NASDAQ:IOBT
|
-20.283x |
|
Flowtech Fluidpower plc
LSE:FLO
|
-0.022x |
|
Enersize Oy
ST:ENERS
|
0.057x |
|
Gyldendal A/S
CO:GYLD-B
|
0.262x |
|
IRWIN NATURALS INC.
F:97X
|
N/A |
|
Everyman Media Group plc
LSE:EMAN
|
0.406x |
|
LeoNovus Inc
V:LTV
|
-0.001x |
Annual Cash Flow Conversion Efficiency for The Hydration Pharmaceuticals Company Ltd (2018–2024)
The table below shows the annual cash flow conversion efficiency of The Hydration Pharmaceuticals Company Ltd from 2018 to 2024. Review how financially flexible is The Hydration Pharmaceuticals Company Lt to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$2.74 Million ≈ $1.94 Million |
AU$-3.02 Million ≈ $-2.14 Million |
-1.101x | -106.89% |
| 2023-12-31 | AU$-358.25K ≈ $-253.49K |
AU$-5.73 Million ≈ $-4.05 Million |
15.993x | +752.93% |
| 2022-12-31 | AU$3.98 Million ≈ $2.82 Million |
AU$-9.75 Million ≈ $-6.90 Million |
-2.449x | -301.06% |
| 2021-12-31 | AU$13.23 Million ≈ $9.36 Million |
AU$-8.08 Million ≈ $-5.72 Million |
-0.611x | +68.33% |
| 2020-12-31 | AU$2.00 Million ≈ $1.42 Million |
AU$-3.86 Million ≈ $-2.73 Million |
-1.928x | -69.48% |
| 2019-12-31 | AU$2.44 Million ≈ $1.73 Million |
AU$-2.78 Million ≈ $-1.97 Million |
-1.138x | +43.84% |
| 2018-12-31 | AU$2.66 Million ≈ $1.88 Million |
AU$-5.40 Million ≈ $-3.82 Million |
-2.026x | -- |
About The Hydration Pharmaceuticals Company Ltd
The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. The company sells its products under the Hydralyte brand through retail stores and online. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is based in Melbourne, Australi… Read more